Bromhidrosis Disease Treatment Market Size to Grow by 362.76 Mn, Increasing Number of M&A by Vendors to be a Key Trend - Technavio

09 Nov 2022
www.prnewswire.com
AcquisitionCollaborate
NEW YORK, Nov. 9, 2022 /PRNewswire/ -- The bromhidrosis disease treatment market size is expected to grow by USD 362.76 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 8.92% during the forecast period, according to Technavio. The market has been segmented by type geography (North America, Europe, Asia, and Rest of World (ROW) and (apocrine body odor and eccrine body odor). Get a comprehensive report summary that describes the market size and forecast along with research methodology. The FREE sample report is available in PDF format
Continue Reading
Bromhidrosis Disease Treatment Market Size to Grow by 362.76 Mn, Increasing Number of M&A by Vendors to be a Key Trend - Technavio
Preview
Source: PRNewswire
Technavio has announced its latest market research report titled Global Bromhidrosis Disease Treatment Market 2022-2026
The rise in the number of patients affected by diabetes and kidney diseases, government awareness programs about the disease, and an increase in healthcare affordability in the US are some of the major factors propelling the market growth. However, factors such as the high cost of treatment, rise in the cost of R&D activities, and lack of knowledge of the disease will hamper the market growth.
More details: https://www.technavio.com/report/bromhidrosis-disease-treatment-market-industry-analysis
Bromhidrosis Disease Treatment Market: Trend
The
increasing M&As is a key trend shaping the bromhidrosis disease treatment market. The key vendors are acquiring small vendors to gain access to new products and technologies at low costs. For instance, in February 2022, Ipsen Pharma partnered with Mayoly Spindler to sell its global consumer healthcare business. In May 2022, Pfizer Inc. announced the acquisition of Biohaven Pharmaceutical Holding Company Ltd. In January 2022, Novartis AG partnered with AlnylamAlnylam to work on targeted therapy to restore liver function. Thus, the rise in the number of M&A will support the growth of the market in the coming years.
Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. Buy Now for detailed information about market dynamics
Bromhidrosis Disease Treatment Market: Type Landscape
By type, the
apocrine body odor segment will be a significant contributor to market growth during the forecast period. Apocrine sweat, when discharged, is colorless and odorless. In apocrine bromhidrosis, body odor is caused due to the combination of lipid-rich apocrine gland perspiration with microorganisms on the skin. This leads to the formation of thioalcohol. Thus, the increase in the number of people with apocrine bromhidrosis will drive the growth of the segment during the forecast period.
Bromhidrosis Disease Treatment Market: Geographic Landscape
By geography,
North America is going to have lucrative growth during the forecast period. About 38% of the market's overall growth is expected to originate from the region. The US and Canada are the key markets for bromhidrosis disease treatment in North America. The growth of the market in the region is attributed to factors such as rising healthcare expenditures, a well-developed healthcare sector, a large patient population, and government backing for R&D.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
Bromhidrosis Disease Treatment Market: Companies Covered
AbbVie Inc. - The company offers bromhidrosis disease treatment, namely Botox.
Galderma SA - The company offers bromhidrosis disease treatment, namely Alluzience.
Hikma Pharmaceuticals Plc - The company offers bromhidrosis disease treatment, namely Glycopyrrolate injection.
Ipsen Pharma - The company offers bromhidrosis disease treatment, namely Dysport.
Biovencer Healthcare Pvt. Ltd.
Johnson & Johnson - The company offers bromhidrosis disease treatment, namely Ditropan XLDitropan XL, through its subsidiary Janssen.
Merz Pharma GmbH & Co. KGaA
Bromhidrosis Disease Treatment Market: What our reports offer
Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers market data from 2021 to 2026
Market trends (threats, challenges, drivers, investment opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping recording the key common trends
Company profiling with financials, detailed strategies, and recent developments
Supply chain trends mapping the latest technological advancements
Get lifetime access to our Technavio Insights! Subscribe to our Basic Plan billed annually at USD 5000
Related Reports
Gastrointestinal Diseases Therapeutics Market by Drug Class and Geography - Forecast and Analysis 2022-2026: The increasing incidence of gastrointestinal diseases is driving market growth. Gastrointestinal diseases have increased significantly across the globe. Improper diet, inactive lifestyle, stress, food sensitivity, and bacterial or viral infection are the major factors contributing to the increasing incidence of chronic and acute gastrointestinal diseases.
Celiac Diseases Drugs Market by Therapy Type and Geography - Forecast and Analysis 2022-2026: Higher consumption of gluten-containing food is driving the market growth. Celiac disease is characterized by an increase in gluten deposition in the body due to the high consumption of food containing gluten. Pizza, cake, soups, beer, bread, cookies, pasta, and burgers are some of the widely consumed food that contains gluten.
Browse Health Care Market Reports
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Apocrine body odor - Market size and forecast 2021-2026
Exhibit 28: Chart on Apocrine body odor - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Apocrine body odor - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Apocrine body odor - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Apocrine body odor - Year-over-year growth 2021-2026 (%)
5.4 Eccrine body odor - Market size and forecast 2021-2026
Exhibit 32: Chart on Eccrine body odor - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Eccrine body odor - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Eccrine body odor - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Eccrine body odor - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
Exhibit 85: AbbVie Inc. - Overview
Exhibit 86: AbbVie Inc. - Product / Service
Exhibit 87: AbbVie Inc. - Key offerings
Exhibit 89: Boehringer Ingelheim International GmbH - Business segments
Exhibit 91: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 92: Boehringer Ingelheim International GmbH - Segment focus
Exhibit 93: Galderma SA - Overview
Exhibit 94: Galderma SA - Product / Service
Exhibit 95: Galderma SA - Key news
Exhibit 96: Galderma SA - Key offerings
Exhibit 97: Hikma Pharmaceuticals Plc - Overview
Exhibit 98: Hikma Pharmaceuticals Plc - Business segments
Exhibit 99: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 100: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 101: Ipsen Pharma - Overview
Exhibit 102: Ipsen Pharma - Business segments
Exhibit 103: Ipsen Pharma - Key offerings
Exhibit 104: Ipsen Pharma - Segment focus
10.8 Johnson and Johnson
Exhibit 105: Johnson and Johnson - Overview
Exhibit 106: Johnson and Johnson - Business segments
Exhibit 107: Johnson and Johnson - Key news
Exhibit 108: Johnson and Johnson - Key offerings
Exhibit 109: Johnson and Johnson - Segment focus
Exhibit 110: Medytox Inc. - Overview
Exhibit 111: Medytox Inc. - Product / Service
Exhibit 112: Medytox Inc. - Key offerings
10.10 Merz Pharma GmbH and Co. KGaA
Exhibit 113: Merz Pharma GmbH and Co. KGaA - Overview
Exhibit 114: Merz Pharma GmbH and Co. KGaA - Product / Service
Exhibit 115: Merz Pharma GmbH and Co. KGaA - Key offerings
Exhibit 116: Novartis AG - Overview
Exhibit 117: Novartis AG - Business segments
Exhibit 118: Novartis AG - Key offerings
Exhibit 119: Novartis AG - Segment focus
Exhibit 120: Pfizer Inc. - Overview
Exhibit 121: Pfizer Inc. - Product / Service
Exhibit 122: Pfizer Inc. - Key news
Exhibit 123: Pfizer Inc. - Key offerings
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 124: Inclusions checklist
Exhibit 125: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 126: Currency conversion rates for US$
11.4 Research methodology
Exhibit 127: Research methodology
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.